Yongming Dai Selected Research

Yongming Dai Research Topics

10	Neoplasms (Cancer) 03/2024 - 01/2013
6	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 05/2022
2	Hemorrhage 04/2014 - 01/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2014 - 01/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2013 - 01/2013
1	Cholangiocarcinoma 11/2023
1	Liver Diseases (Liver Disease) 08/2023
1	Fibrosis (Cirrhosis) 08/2023
1	Glioma (Gliomas) 04/2023
1	Calculi (Calculus) 05/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Metabolic Bone Diseases (Osteopenia) 01/2021
1	Osteoporosis 01/2021
1	Stroke (Strokes) 11/2020
1	Deafness (Deaf Mutism) 10/2018
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2017
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Osteoarthritis 10/2012
1	Parkinson Disease (Parkinson's Disease) 05/2010

6	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2013
5	alpha-Fetoproteins (alpha-Fetoprotein)IBA 03/2024 - 01/2023
4	IronIBA 04/2017 - 05/2010
2	gadolinium ethoxybenzyl DTPA FDA Link 12/2023 - 01/2023
2	Keratin-19 (Keratin 19)IBA 01/2023 - 05/2022
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2013
2	GadoliniumIBA 01/2013 - 10/2012
1	AntigensIBA 08/2023
1	CarbohydratesIBA 08/2023
1	Capsules (Microcapsules)IBA 08/2023
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2023
1	GlypicansIBA 01/2023
1	Estrogen ReceptorsIBA 01/2023
1	Protons (Proton)IBA 01/2021
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 10/2018
1	deoxyhemoglobinIBA 04/2017
1	Contrast MediaIBA 04/2014
1	P 11 (P-11)IBA 01/2014

1	Hearing Aids (Hearing Aid) 10/2018
1	Therapeutics 01/2013